Search research articles
Contact Us
Filters
Showing results (221-230 of 232) with videos related to
Page
of 24
Sort By:
The Journal of Clinical Investigation
|
October 1, 2019
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial
Nadine G Rouphael, Cecilia Morgan, Shuying S Li, et al.
Frontiers in Immunology
|
August 8, 2022
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study
Beatriz Perdiguero, Benedikt Asbach, Carmen E Gómez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2020
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein
Mina C Hosseinipour, Craig Innes, Sarita Naidoo, et al.
Journal of Virology
|
February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Journal of Virology
|
November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology
|
October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 25, 2024
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial
Nigel Garrett, One Dintwe, Cynthia L Monaco, et al.
Journal of Virology
|
June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Journal of Virology
|
May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
Xiaoying Shen, Ryan Duffy, Robert Howington, et al.
Journal of Virology
|
November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost
Benedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 232) with videos related to
Sort By:
Page
of 24
The Journal of Clinical Investigation
|
October 1, 2019
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial
Nadine G Rouphael, Cecilia Morgan, Shuying S Li, et al.
Frontiers in Immunology
|
August 8, 2022
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study
Beatriz Perdiguero, Benedikt Asbach, Carmen E Gómez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2020
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein
Mina C Hosseinipour, Craig Innes, Sarita Naidoo, et al.
Journal of Virology
|
February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Journal of Virology
|
November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology
|
October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 25, 2024
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial
Nigel Garrett, One Dintwe, Cynthia L Monaco, et al.
Journal of Virology
|
June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Journal of Virology
|
May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
Xiaoying Shen, Ryan Duffy, Robert Howington, et al.
Journal of Virology
|
November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost
Benedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Page
of 24